Home › Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
 

Keywords :   


Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial

2014-06-11 16:23:49| Biotech - Topix.net

Encouraging single-agent CYRAMZA activity was observed, with meaningful improvements in key secondary endpoints of progression-free survival, overall response rate and time to progression.

Tags: results iii trial phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Digital video subscriptions to reach 3.5 billion by 2028
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
More »